Paul J. Kelly, Nancy U. Lin, Elizabeth B. Claus, Eudocia C. Quant, Stephanie E. Weiss and Brian M. Alexander Salvage stereotactic radiosurgery for breast cancer brain metastases Cancer 118
Version of Record online: 14 SEP 2011 | DOI: 10.1002/cncr.26343
In patients with good Karnofsky performance status, salvage stereotactic radiosurgery (SRS) for breast cancer brain metastases is a reasonable treatment option, given an associated median survival in excess of 9 months. Furthermore, patients with HER2-positive tumors at diagnosis or stable extracranial disease at the time of SRS have an improved clinical course, with median survival of >1 year.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field